TD Asset Management
ETRM

TD Asset Management’s EnteroMedics Inc. ETRM Stock Holding History

TD Asset Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-81
Closed -$52K – 1438
2015
Q2 		$52K Hold
81
– – ﹤0.01% 1394
2015
Q1 		$77K Buy
81
+1
+1% +$1.21K ﹤0.01% 1375
2014
Q4 		$119K Hold
80
– – ﹤0.01% 1362
2014
Q3 		$103K Hold
80
– – ﹤0.01% 1297
2014
Q2 		$130K Hold
80
– – ﹤0.01% 1268
2014
Q1 		$152K Buy
80
+10
+14% +$23.7K ﹤0.01% 1265
2013
Q4 		$151K Hold
70
– – ﹤0.01% 1256
2013
Q3 		$92K Hold
70
– – ﹤0.01% 1241
2013
Q2 		$84K Buy
+70
New +$73.9K ﹤0.01% 1178

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Asset Management's ETRM Position: Q3 2015 in Review

TD Asset Management sold out of EnteroMedics Inc. (ETRM) in Q3 2015, closing a stake of 81 shares — an estimated $52K sold.

TD Asset Management first reported a position in ETRM in Q2 2013 and held it in 9 quarters. The position peaked at $152K in Q1 2014. 41 funds tracked by Wall St. Rank hold ETRM as of Q3 2015.

  • TD Asset Management reported no remaining EnteroMedics Inc. position as of Q3 2015 after selling out during the quarter.
  • TD Asset Management sold 81 EnteroMedics Inc. shares in Q3 2015, an estimated $52K.
  • TD Asset Management first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 9 quarters.
  • TD Asset Management's EnteroMedics Inc. position peaked at $152K in Q1 2014.
  • 41 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2015.

Based on TD Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.